193 related articles for article (PubMed ID: 38663962)
1. Emerging trends in gastrointestinal cancers: Targeting developmental pathways in carcinogenesis and tumor progression.
Ahmad A; Tiwari RK; Siddiqui S; Chadha M; Shukla R; Srivastava V
Int Rev Cell Mol Biol; 2024; 385():41-99. PubMed ID: 38663962
[TBL] [Abstract][Full Text] [Related]
2. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
[TBL] [Abstract][Full Text] [Related]
3. The Hippo and Wnt signalling pathways: crosstalk during neoplastic progression in gastrointestinal tissue.
Li N; Lu N; Xie C
FEBS J; 2019 Oct; 286(19):3745-3756. PubMed ID: 31342636
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options.
Kopp R; Rothbauer E; Ruge M; Arnholdt H; Spranger J; Muders M; Pfeiffer DG; Schildberg FW; Pfeiffer A
Recent Results Cancer Res; 2003; 162():115-32. PubMed ID: 12790326
[TBL] [Abstract][Full Text] [Related]
5. Role of ion channels in gastrointestinal cancer.
Anderson KJ; Cormier RT; Scott PM
World J Gastroenterol; 2019 Oct; 25(38):5732-5772. PubMed ID: 31636470
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment.
Merchant JL; Saqui-Salces M
Cancer Treat Rev; 2014 Feb; 40(1):12-21. PubMed ID: 24007940
[TBL] [Abstract][Full Text] [Related]
7. The roles of PD-1/PD-L1 and its signalling pathway in gastrointestinal tract cancers.
Cui C; Yu B; Jiang Q; Li X; Shi K; Yang Z
Clin Exp Pharmacol Physiol; 2019 Jan; 46(1):3-10. PubMed ID: 30161295
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between oxidative stress signaling and microRNA regulatory systems in carcinogenesis: Focused on gastrointestinal cancers.
Akbari A; Majd HM; Rahnama R; Heshmati J; Morvaridzadeh M; Agah S; Amini SM; Masoodi M
Biomed Pharmacother; 2020 Nov; 131():110729. PubMed ID: 33152911
[TBL] [Abstract][Full Text] [Related]
9. Regulation of EMT by KLF4 in gastrointestinal cancer.
Cui J; Shi M; Quan M; Xie K
Curr Cancer Drug Targets; 2013 Nov; 13(9):986-95. PubMed ID: 24168184
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of KLF4 in human gastrointestinal cancer.
Wei D; Kanai M; Huang S; Xie K
Carcinogenesis; 2006 Jan; 27(1):23-31. PubMed ID: 16219632
[TBL] [Abstract][Full Text] [Related]
11. NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors?
Huang T; Zhou Y; Cheng AS; Yu J; To KF; Kang W
Mol Cancer; 2016 Dec; 15(1):80. PubMed ID: 27938406
[TBL] [Abstract][Full Text] [Related]
12. EGFR(s) in aging and carcinogenesis of the gastrointestinal tract.
Nautiyal J; Kanwar SS; Majumdar AP
Curr Protein Pept Sci; 2010 Sep; 11(6):436-50. PubMed ID: 20491625
[TBL] [Abstract][Full Text] [Related]
13. Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog.
Nwabo Kamdje AH; Takam Kamga P; Tagne Simo R; Vecchio L; Seke Etet PF; Muller JM; Bassi G; Lukong E; Kumar Goel R; Mbo Amvene J; Krampera M
Cancer Biol Med; 2017 May; 14(2):109-120. PubMed ID: 28607802
[TBL] [Abstract][Full Text] [Related]
14. Obesity-associated digestive cancers: A review of mechanisms and interventions.
Zheng J; Zhao M; Li J; Lou G; Yuan Y; Bu S; Xi Y
Tumour Biol; 2017 Mar; 39(3):1010428317695020. PubMed ID: 28351315
[TBL] [Abstract][Full Text] [Related]
15. The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms.
Mima K; Ogino S; Nakagawa S; Sawayama H; Kinoshita K; Krashima R; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Sakamoto Y; Yamashita YI; Yoshida N; Chikamoto A; Ishiko T; Baba H
Surg Oncol; 2017 Dec; 26(4):368-376. PubMed ID: 29113654
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid in digestive cancers.
Wu RL; Huang L; Zhao HC; Geng XP
J Cancer Res Clin Oncol; 2017 Jan; 143(1):1-16. PubMed ID: 27535565
[TBL] [Abstract][Full Text] [Related]
17. Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: rationale and progress.
Gholamin S; Fiuji H; Maftouh M; Mirhafez R; Shandiz FH; Avan A
Curr Drug Targets; 2014; 15(14):1302-11. PubMed ID: 25382190
[TBL] [Abstract][Full Text] [Related]
18. Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Evidence.
Narayanankutty A; Nambiattil S; Mannarakkal S
Recent Pat Anticancer Drug Discov; 2023; 18(3):307-324. PubMed ID: 35670354
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms.
Wu WK; Sung JJ; Lee CW; Yu J; Cho CH
Cancer Lett; 2010 Sep; 295(1):7-16. PubMed ID: 20381235
[TBL] [Abstract][Full Text] [Related]
20. The Role of Epidermal Growth Factor Receptor in the Management of Gastrointestinal Carcinomas: Present Status and Future Perspectives.
Mahmood MQ; Shukla SD; Dua K; Shastri MD
Curr Pharm Des; 2017; 23(16):2314-2320. PubMed ID: 28120720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
